GRAMD4 抗体 (full length)
Our Local Distributor
北京 101111
Quick Overview for GRAMD4 抗体 (full length) (ABIN7878319)
抗原
See all GRAMD4 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- full length
-
原理
- GRAMD4 Antibody
-
纯化方法
- Protein A/G affinity
-
免疫原
- Recombinant full-length human GRAMD4 protein was used as the immunogen for the GRAMD4 antibody.
-
亚型
- IgG1
-
-
-
-
应用备注
- Optimal dilution of the GRAMD4 antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.2 mg/mL
-
缓冲液
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Aliquot the GRAMD4 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- GRAMD4 (GRAM Domain Containing 4 (GRAMD4))
-
别名
- GRAMD4
-
背景
- The gene encoding GRAMD4 (GRAM domain-containing protein 4) maps to human chromosome 22, which houses over 500 genes and is the second smallest human chromosome. GRAMD4, also designated death-inducing protein (DIP), is a 578 amino acid mitochondrial membrane protein that acts as an essential mediator of the p53-independent E2F-1 death pathway, which is frequently found to be deregulated in several types of cancers. Overexpression of GRAMD4 results in a strong apoptotic response involving caspase-3 activation and cleavage of poly(ADP-ribose)-polymerase. GRAMD4 is expressed in lung and in primary lung squamous cell carcinoma (LSCC) and shows upregulation in mitochondria by E2F1 after addition of 4-hydroxytamoxifen. This evidence suggests that GRAMD4 may be a potential target for cancer therapies.
-
UniProt
- Q6IC98
抗原
-